tiprankstipranks
Trending News
More News >
Viva Biotech Holdings (HK:1873)
:1873
Hong Kong Market

Viva Biotech Holdings (1873) Financial Statements

Compare
3 Followers

Viva Biotech Holdings Financial Overview

Viva Biotech Holdings's market cap is currently HK$4.36B. The company's EPS TTM is HK$0.0545991605; its P/E ratio is 23.60; Viva Biotech Holdings is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.99B¥ 2.16B¥ 2.38B¥ 2.10B¥ 696.96M
Gross Profit¥ 687.40M¥ 738.43M¥ 815.68M¥ 650.98M¥ 304.87M
Operating Income¥ 229.67M¥ 192.68M¥ 269.35M¥ 236.90M¥ 115.57M
EBITDA¥ 428.00M¥ 391.01M¥ 436.35M¥ 369.94M¥ 164.35M
Net Income¥ 167.29M¥ -116.11M¥ -528.48M¥ 287.55M¥ -386.88M
Balance Sheet
Cash & Short-Term Investments¥ 941.58M¥ 1.04B¥ 678.57M¥ 800.95M¥ 2.36B
Total Assets¥ 7.05B¥ 7.45B¥ 7.92B¥ 8.04B¥ 8.15B
Total Debt¥ 1.28B¥ 1.90B¥ 2.82B¥ 2.65B¥ 2.97B
Net Debt¥ 342.47M¥ 866.89M¥ 2.14B¥ 1.85B¥ 661.06M
Total Liabilities¥ 3.23B¥ 3.76B¥ 4.32B¥ 4.13B¥ 4.40B
Stockholders' Equity¥ 3.80B¥ 3.69B¥ 3.60B¥ 3.91B¥ 3.76B
Cash Flow
Free Cash Flow¥ 182.32M¥ 195.57M¥ 136.72M¥ -487.35M¥ -549.44M
Operating Cash Flow¥ 373.99M¥ 383.40M¥ 386.05M¥ 77.83M¥ 43.18M
Investing Cash Flow¥ 185.90M¥ 439.17M¥ -372.80M¥ -868.84M¥ -3.85B
Financing Cash Flow¥ -657.76M¥ -429.50M¥ -143.20M¥ -653.16M¥ 5.31B
Currency in CNY

Viva Biotech Holdings Earnings and Revenue History

Viva Biotech Holdings Debt to Assets

Viva Biotech Holdings Cash Flow

Viva Biotech Holdings Forecast EPS vs Actual EPS